Clinical Trial

OPM- MEG in Non-immune And iMmune-medIated Neurological Disease

Study acronym: O-MEG-A-MIND
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Over the past 20 years, doctors have gotten much better at spotting and treating brain conditions caused by the immune system attacking the body. These include illnesses like autoimmune encephalitis, ADEM, and multiple sclerosis. But even with better treatments, many patients-especially children-still struggle with long-term problems. Standard brain scans and tests often miss important issues like memory problems, emotional difficulties, trouble sleeping, and challenges with social behaviour. Early research using a special brain imaging technique (called MEG) has shown changes in brain networks that seem to be linked to poor memory. This study will use a new, advanced version of MEG that works even with very young children (as young as 2 years old). The goal is to better understand how these brain conditions affect children, compare them with other types of brain illness, and eventually use this technology to help predict outcomes and discover new ways to track brain health.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-01.
Trial Details
NCT Number NCT07689682
Lead Sponsor Aston University
Collaborators: Birmingham Children's Hospital, United Kingdom
Conditions Autoimmune Encephalitis (AE), Acute Disseminated Encephalomyelitis, Multiple Sclerosis
Enrollment 90 participants
Start Date 2026-05-15
Primary Completion 2034-09-15 (estimated)
Study Completion 2034-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-09